Live Breaking News & Updates on Neurocrine biosciences

Stay informed with the latest breaking news from Neurocrine biosciences on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Neurocrine biosciences and stay connected to the pulse of your community

The Week in Review: April 22-26

Here are highlights from the week in Psychiatric Times.

United-states , Jenny-taitz , Neurocrine-biosciences , Chepko-danil , Psychiatric-times , Adults-with-major-depressive , Psychological-symptoms , Between-food-additives , Fellow-psychiatrists , Still-have-work , Wall-street-journal , Anti-anxiety-drugs

BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates

EQS-News: BB BIOTECH AG

/ Key word: Interim Report

BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates...

Germany , Schaffhausen , Switzerland , Japan , Swiss , German , Maria-grazia-alderuccio , Erich-hunziker , Krogsgaard-thomsen , Thomas-egger , Pearl-huang , Clive-meanwell

Novartis, Neurocrine-Takeda, Enhertu—Fierce Pharma Asia

Novartis, Neurocrine-Takeda, Enhertu—Fierce Pharma Asia
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

China , Dong-liu , Anhui , Chinese , Harry-kirsch , Alex-scott , Daiichi-sankyo , Shaojiang-deng , Neurocrine-biosciences , Daiichi-sankyo-enhertu , Novartis , Astrazeneca

Rx Rundown: Xaira Therapeutics, Ipsen, Sanofi and more

Check out this week’s medical marketing news, dealmaking and industry chatter.

Italy , San-diego , California , United-states , Switzerland , Colorado , Sweden , Bern , Ireland , Boulder , Tessera , Veneto

Yousif Capital Management LLC Sells 370 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

Yousif Capital Management LLC cut its holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 0.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 46,808 shares of the company’s stock after selling 370 shares during the quarter. Yousif Capital Management LLC’s […]

United-states , Eric-benevich , Neurocrine-biosciences , Sunbelt-securities-inc , Jpmorgan-chase-co , Lindbrook-capital , Neurocrine-biosciences-inc , Red-spruce-capital , Neurocrine-biosciences-company-profile , Wells-fargo-company , Nasdaq , Yousif-capital-management

Stock Market Rebounds; Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review

Stock Market Rebounds; Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

United-states , Texas , Mexico , Boston , Massachusetts , America , Mexican , Elon-musk , Mark-zuckerberg , Bristol-myers-squibb , Deutsche-telekom , David-calhoun

New York State Common Retirement Fund Has $28.25 Million Stock Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

New York State Common Retirement Fund lessened its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 12.1% during the 4th quarter, Holdings Channel reports. The firm owned 214,396 shares of the company’s stock after selling 29,456 shares during the quarter. New York State Common Retirement Fund’s holdings in Neurocrine Biosciences were worth $28,249,000 […]

New-york , United-states , Ingrid-delaet , Eric-benevich , Neurocrine-biosciences , Securities-exchange-commission , Neurocrine-biosciences-inc , Red-spruce-capital , Barclays , Sunbelt-securities-inc , Lindbrook-capital , Goldman-sachs-group

New York State Common Retirement Fund Sells 29,456 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

New York State Common Retirement Fund lessened its stake in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 12.1% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 214,396 shares of the company’s stock after selling 29,456 shares during the period. New York State Common […]

New-york , United-states , Neurocrine-biosciences , Eiry-roberts , Kevin-charles-gorman , Nasdaq , Citigroup , Wells-fargo-company , Metis-global-partners , Red-spruce-capital , Lindbrook-capital , York-state-common-retirement-fund

CBS 8 celebrates its neighbor A.O. Reed

The plumbing pipe company is celebrating it's 110th year in business.

California , United-states , San-diego , Petco-park , Salk-institute , Neurocrine-biosciences , Chuck-lawrence , Larry-himmel , Steve-andrade , Dan-jordison , Ao-reed-co , O-reed-co

Neurocrine Biosciences (NASDAQ:NBIX) Stock Rating Reaffirmed by Needham & Company LLC

Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report)‘s stock had its “hold” rating restated by investment analysts at Needham & Company LLC in a report released on Tuesday, Benzinga reports. Other equities research analysts have also issued research reports about the company. Wells Fargo & Company upped their target price on Neurocrine Biosciences from $127.00 to […]

United-states , Los-angeles , California , Davidw-boyer , Neurocrine-biosciences , Ingrid-delaet , Wells-fargo-company , Securities-exchange-commission , Needham-company , Vanguard-group-inc , Brown-advisory-inc , Capital-partners